ElucidVivo Research Edition

Progressive application of machine intelligence as a proving ground for Clinical Edition enhancements, including FFRct & Event Prediction

image001 (1).png

Additional measurements:

  • Intraplaque hemorrhage (IPH)

​​

  • Automated cap thickness

​​

  • Systemic inflammation markers (e.g., PVAT)

Machine Intelligence Models:

  • High-Risk Plaque (HRP) Phenotyping

​

  • Fractional Flow Reserve (FFRct)

​​

  • MACE and MANE prediction

​​

  • Dominant molecular mechanism

​​

  • Longitudinal atherogenic vs. atheroprotective phenotype adjusted for age and sub-type

Request a Demo
First FDA-cleared use of advanced knowledge representation, and roadmap of progressive and robust machine intelligence

Reporting for the referring physician:

  • Interactive report displaying discrete measurements of key properties along the vessel

​​

  • Longitudinal progression/regression plots

​​

  • Easy toggle to narrative version of report to provide easily-digestible key takeaways for provider note

Patient Reporting Extensions:

  • Reference cohorts: normal vs. diseased ranges

​​

  • Natural Language generation of Findings with Automatic Lesion Detection

​​

  • Per-patient prediction models of adverse outcome

Request a Demo